Icosavax, Inc.
NASDAQ:ICVX
15.31 (USD) • At close February 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Operating Activities: | ||||
| Net Income
| -91.758 | -66.971 | -18.854 | -5.297 |
| Depreciation & Amortization
| 0.86 | 0.082 | 0.001 | 0 |
| Deferred Income Tax
| 0 | 0.959 | -0.187 | 0 |
| Stock Based Compensation
| 21.694 | 29.031 | 0.257 | 0.072 |
| Change In Working Capital
| 8.074 | -1.905 | 4.158 | 0.656 |
| Accounts Receivables
| 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 |
| Accounts Payables
| -1.195 | 1.839 | 1.119 | 0.452 |
| Other Working Capital
| 9.269 | -3.744 | 3.039 | 0.204 |
| Other Non Cash Items
| -0.545 | 0.264 | 0.417 | 0 |
| Operating Cash Flow
| -61.675 | -38.54 | -14.208 | -4.569 |
| Investing Activities: | ||||
| Investments In Property Plant And Equipment
| -11.113 | -1.006 | -0.011 | 0 |
| Acquisitions Net
| 158.336 | 0 | 0 | 0 |
| Purchases Of Investments
| -221.086 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 62.75 | 0 | 0 | 0 |
| Other Investing Activites
| -158.336 | 0 | 0 | 0 |
| Investing Cash Flow
| -169.449 | -1.006 | -0.011 | 0 |
| Financing Activities: | ||||
| Debt Repayment
| 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 190.738 | 0.174 | 26.742 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 |
| Other Financing Activities
| 10.307 | 304.772 | 6.638 | 26.742 |
| Financing Cash Flow
| 10.307 | 304.772 | 6.638 | 26.742 |
| Other Information: | ||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 |
| Net Change In Cash
| -220.817 | 265.226 | -7.581 | 22.173 |
| Cash At End Of Period
| 59.907 | 280.724 | 15.498 | 23.079 |